LEADER 03738nam  22006615  450 
001 9910254527403321
005 20260812171139.0
010   $a3-319-21434-9
024 7 $a10.1007/978-3-319-21434-4
035   $a(CKB)3710000000467552
035   $a(EBL)4178391
035   $a(SSID)ssj0001546639
035   $a(PQKBManifestationID)16141215
035   $a(PQKBTitleCode)TC0001546639
035   $a(PQKBWorkID)14796490
035   $a(PQKB)10271691
035   $a(DE-He213)978-3-319-21434-4
035   $a(MiAaPQ)EBC4178391
035   $a(PPN)188457844
035   $a(EXLCZ)993710000000467552
100   $a20150827d2016      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAntiepileptic Drugs and Pregnancy $eA Guide for Prescribers /$fby MJ Eadie, FJE Vajda
205   $a1st ed. 2016.
210  1$aCham :$cSpringer International Publishing :$cImprint: Adis,$d2016.
215   $a1 online resource (235 p.)
300   $aDescription based upon print version of record.
311 08$a3-319-21433-0 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $a1. Introduction -- 2. Antiepileptic drugs and becoming pregnant -- Part I. Antiepileptic Drug Pharmacokinetics in Pregnancy -- 3. Antiepileptic drug disposition and pregnancy -- 4. The older antiepileptic drugs -- 5. Commonly used newer antiepileptic drugs -- 6. Antiepileptic drugs sometimes used in pregnancy -- Part II. Antiepileptic Drugs and the Foetus -- 7. Antiepileptic drugs, epileptic seizures and the foetus -- 8. Antiepileptic drugs and foetal malformations - a possible class effect -- 9. Particular antiepileptic drugs and foetal malformations -- 10. Antiepileptic drugs, cognition and neurodevelopment -- Part III. Antiepileptic Drug use and Pregnancy -- 11. Antiepileptic drug therapy: management issues and pregnancy -- 12. Antiepileptic drugs and pregnancy – the future.
330   $aA description of our current understanding of antiepileptic drug use during pregnancy, this book includes chapters on the impact of seizures on the mother and developing child, changes in maternal physiology during pregnancy and its impact on drug disposition, and the pharmacokinetic differences between the various anti-seizure medications. It also deals with the possible harmful effects of antiepileptic drug exposure during pregnancy on the physical and intellectual development of the fetus. Clinicians have to balance the potential adverse effects of the medicine for the fetus and mother-to-be against the risks that uncontrolled seizures hold for both when treating pregnant women with antiepileptic drugs. Only recently have enough scientific data emerged to provide a rational basis for treatment decisions that take in both aspects. This work provides a single, accessible, and up-to-date resource for busy clinicians.
606   $aFamily medicine
606   $aMidwifery
606   $aGynecology
606   $aNeurology
606   $aGeneral Practice and Family Medicine
606   $aMidwifery
606   $aGynecology
606   $aNeurology
615  0$aFamily medicine.
615  0$aMidwifery.
615  0$aGynecology.
615  0$aNeurology.
615 14$aGeneral Practice and Family Medicine.
615 24$aMidwifery.
615 24$aGynecology.
615 24$aNeurology.
676   $a610
700   $aEadie$b Mervyn J.$4aut$4http://id.loc.gov/vocabulary/relators/aut$01147719
702   $aVajda$b FJE$4aut$4http://id.loc.gov/vocabulary/relators/aut
906   $aBOOK
912   $a9910254527403321
996   $aAntiepileptic Drugs and Pregnancy$93391958
997   $aUNINA